Naik M, Naik N, Hu T, Wang S, Marshall J
FEBS Lett. 2023; 598(2):233-241.
PMID: 37904289
PMC: 10842001.
DOI: 10.1002/1873-3468.14767.
Hegedus Z, Hobor F, Shoemark D, Celis S, Lian L, Trinh C
Chem Sci. 2021; 12(6):2286-2293.
PMID: 34163995
PMC: 8179271.
DOI: 10.1039/d0sc05694d.
Bozovic O, Jankovic B, Hamm P
Nat Commun. 2020; 11(1):5841.
PMID: 33203849
PMC: 7673989.
DOI: 10.1038/s41467-020-19689-7.
Christensen N, calyseva J, Fernandes E, Luchow S, Clemmensen L, Haugaard-Kedstrom L
Adv Ther (Weinh). 2020; 2(7):1800143.
PMID: 32313833
PMC: 7161847.
DOI: 10.1002/adtp.201800143.
Wang Y, Distefano M
Curr Top Pept Protein Res. 2017; 15:1-23.
PMID: 28239240
PMC: 5321655.
Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain.
Amacher J, Zhao R, Spaller M, Madden D
PLoS One. 2014; 9(8):e103650.
PMID: 25136860
PMC: 4138078.
DOI: 10.1371/journal.pone.0103650.
Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.
Pal K, Pletnev A, Dutta S, Wang E, Zhao R, Baral A
Mol Cancer Ther. 2014; 13(10):2264-75.
PMID: 25125675
PMC: 4229952.
DOI: 10.1158/1535-7163.MCT-14-0291.
An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
Tiwari G, Mohanty D
PLoS One. 2013; 8(8):e71340.
PMID: 23951139
PMC: 3738590.
DOI: 10.1371/journal.pone.0071340.
Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.
Ranjan Patra C, Rupasinghe C, Dutta S, Bhattacharya S, Wang E, Spaller M
ACS Chem Biol. 2012; 7(4):770-9.
PMID: 22292614
PMC: 3331932.
DOI: 10.1021/cb200536r.
Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1.
Bach A, Stuhr-Hansen N, Thorsen T, Bork N, Moreira I, Frydenvang K
Org Biomol Chem. 2010; 8(19):4281-8.
PMID: 20668766
PMC: 3614091.
DOI: 10.1039/c0ob00025f.
PDZ domains and their binding partners: structure, specificity, and modification.
Lee H, Zheng J
Cell Commun Signal. 2010; 8:8.
PMID: 20509869
PMC: 2891790.
DOI: 10.1186/1478-811X-8-8.